# Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)

> **NCT02243852** · — · WITHDRAWN · sponsor: **University of Liverpool**

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **DRUG:** Growth Hormone Replacement Therapy

## Key facts

- **NCT ID:** NCT02243852
- **Lead sponsor:** University of Liverpool
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-09
- **Primary completion:** 2015-08
- **Final completion:** 2017-06-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor withdrew support 6th June 2017
- **Last updated:** 2024-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02243852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02243852, "Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02243852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*